[Photo by CordenPharma] Photovoltaic panels installed at CordenPharma Lisbon, Portugal.
We are excited to announce that as of March 2025, after successfully fulfilling the requirements for supplier partnership, CordenPharma have been selected to become a Supplier Partner in the second cohort of the PSCI (Pharmaceutical Supply Chain Initiative).
PSCI is a non-profit association that brings together partners in the pharmaceutical and healthcare industry who share a common vision of ensuring acceptable working conditions, safe processes and facilities, economic development, and environmental sustainability in local communities.
The PSCI’s approach is grounded in five key responsible business practices and supply chain management standards:
The PSCI audit program of our manufacturing sites assesses our performance against these five responsible business practices and supply chain management standards.
During the preparation phase for this partnership, CordenPharma excelled in several key areas, including the handling of high-potency compounds, behavior-based safety (BBS) programs, and risk management practices.
This partnership not only addresses audit requirements from our customers but also supports the continued implementation of CordenPharma’s sustainable procurement program.
William Cashin, Chief Quality & Compliance Officer at CordenPharma comments, “I am proud of the hard work across our global teams on sustainability. Our employees are delighted to achieve supplier partnership status and to demonstrate our commitment to the PSCI Principles. We look forward to sharing future audit results and Maturity Models with transparency and collaborating with customer PSCI members towards our common goal.”
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.